Veeva Systems Inc (NYSE: VEEV)

Veeva Systems Inc operates as a leading provider of industry cloud solutions tailored specifically for the global life sciences sector. The company's offerings span cloud software, data, and business consulting, designed to address the unique needs of life sciences companies across their most strategic business functions, from research and development (R&D) through commercialization. Veeva's solutions aim to help life sciences companies develop and bring products to market faster and more efficiently, market and sell more effectively, and maintain compliance with government regulations. The company's goal is to become the most strategic software, data, and business consulting partner to the life sciences industry, supporting critical functions such as drug development, quality and manufacturing, and commercialization.

Veeva Systems Inc generates revenue through its industry cloud solutions, which are grouped into four major product categories: Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. These solutions cater to pharmaceutical, biotechnology, and medical devices and diagnostics (MedTech) companies, addressing their most pressing strategic needs in commercial, R&D, and quality operations. The company also offers professional services and Veeva Business Consulting to help customers maximize the value of their solutions. Veeva's customer base includes a wide range of life sciences companies, from large global pharmaceutical and biotechnology companies to emerging growth pharmaceutical and biotechnology companies, as well as contract sales organizations and contract research organizations.

• Veeva Development Cloud: This segment includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on the Veeva Vault platform. Key products include Veeva Clinical Platform, Veeva Clinical Data Management, Veeva Safety, and Veeva RIM. These solutions help streamline end-to-end business processes and eliminate manual processes and siloed systems, catering to the R&D and quality operations of life sciences companies.

• Veeva Quality Cloud: This segment unifies quality applications, processes, and partners across content management, training, quality assurance, and quality control lab solutions on the Veeva Vault platform. Key products include Veeva QMS and Veeva Quality Docs, which help life sciences and consumer products industries develop and manufacture products more efficiently.

• Veeva Commercial Cloud: This segment comprises software and analytics solutions built specifically for life sciences companies to more efficiently and effectively commercialize their products. Key products include Veeva Vault CRM Suite, Veeva Medical, Veeva PromoMats, and Veeva Crossix, catering to the sales, marketing, and medical affairs functions of life sciences companies.

• Veeva Data Cloud: This segment is a modern data platform comprised of connected reference data, deep data, and transaction data. Key products include Veeva OpenData, Veeva Link applications, Veeva Compass, and Veeva HCP Access, designed to bring greater efficiency and precision across clinical and commercial operations of life sciences companies.

Veeva Systems Inc holds a strong position within the life sciences industry, competing with other cloud-based solutions from providers that make applications geared toward the life sciences industry. Key competitors include Salesforce, which has developed a life sciences industry-specific CRM application, and IQVIA, which historically offered a competitive CRM solution. Veeva's competitive advantages include its deep domain expertise in life sciences, ease of deployment and use of solutions, breadth and depth of solution functionality, and ability to innovate and respond to customer needs rapidly. The company's modern and adaptive technology platform, capability for customization, configurability, integration, security, scalability, and reliability of applications, and total cost of ownership also contribute to its competitive position.

Veeva Systems Inc serves a diverse customer base, including large global pharmaceutical and biotechnology companies such as Bayer AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Gilead Sciences, Inc., Merck Sharp & Dohme Corp., and Novartis Pharma AG, as well as emerging growth pharmaceutical and biotechnology companies, including Alkermes Inc., Alnylam Pharmaceuticals, Inc., bluebird bio, Inc., and Idorsia Pharmaceuticals Ltd. The company also delivers solutions to companies in the consumer products industries. As of January 31, 2026, Veeva served 1,552 customers, demonstrating its broad reach and impact within the life sciences sector.